In this episode, Tanuja Randery of AWS sits down with Dave Hallett, Chief Science Officer and Interim CEO of Exscientia, to discuss how the company is leveraging AI and cloud technology to transform the drug discovery process. Hallett explains Exscientia's approach to improving efficiency and patient success rates, and explores the importance of partnerships and building diverse, high-performing teams in the rapidly evolving landscape of scientific innovation.

Resources:

Amazon Bedrock: https://aws.amazon.com/bedrock/

Amazon Q: https://aws.amazon.com/q/

AWS Generative AI Innovation Center: https://aws.amazon.com/generative-ai/innovation-center/

Harnessing AI to Revolutionize Drug Discovery